1,406
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Acute kidney injury in autologous hematopoietic stem cell transplant for patients with lymphoma – KDIGO classification with creatinine and urinary output criteria: a cohort analysis

, , , , , , & show all
Article: 2183044 | Received 13 Sep 2022, Accepted 09 Jan 2023, Published online: 01 Mar 2023

References

  • Passweg JR, Baldomero H, Bader P, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant. 2016;51(6):786–792.
  • Clajus C, Hanke N, Gottlieb J, et al. Renal comorbidity after solid organ and stem cell transplantation: renal comorbidity after transplantation. Am J Transplant. 2012;12(7):1691–1699.
  • Eleutherakis-Papaiakovou V, Bamias A, Gika D, et al. Renal failure in multiple myeloma: incidence, correlations, and prognostic significance. Leuk Lymphoma. 2007;48(2):337–341.
  • Parikh CR, McSweeney PA, Korular D, et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int. 2002;62(2):566–573.
  • Wanchoo R, Stotter BR, Bayer RL, et al. Acute kidney injury in hematopoietic stem cell transplantation. Curr Opin Crit Care. 2019;25(6):531–538.
  • Lopes JA, Jorge S, Neves M. Acute kidney injury in HCT: an update. Bone Marrow Transplant. 2016;51(6):755–762.
  • KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1):124–138.
  • Bellomo R, Ronco C, Kellum JA, et al. [No title found]. Crit Care. 2004;8(4):R204.
  • Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
  • Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089–2100.
  • Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912–2919.
  • Iacobelli S, Committee ES, On behalf of the EBMT Statistical Committee. Suggestions on the use of statistical methodologies in studies of the European group for blood and marrow transplantation. Bone Marrow Transplant. 2013;48(S1):S1–S37.
  • Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509.
  • Kanduri SR, Cheungpasitporn W, Thongprayoon C, et al. Incidence and mortality of acute kidney injury in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. QJM. 2020;113(9):621–632.
  • Lopes JA, Jorge S, Silva S, et al. Acute renal failure following myeloablative autologous and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2006;38(10):707–707.
  • Fadia A, Casserly LF, Sanchorawala V, et al. Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int. 2003;63(5):1868–1873.
  • Caliskan Y, Besisik SK, Sargin D, et al. Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2006;38(2):141–147.
  • Merouani A, Shpall EJ, Jones RB, et al. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int. 1996;50(3):1026–1031.
  • Gruss E, Bernis C, Tomas JF, et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol. 1995;15(6):473–479.
  • Cooper BW, Creger RJ, Soegiarso W, et al. Renal dysfunction during high-dose cisplatin therapy and autologous hematopoietic stem cell transplantation: effect of aminoglycoside therapy. Am J Med. 1993;94(5):497–504.
  • Zager RA, Prior RB. Gentamicin and gram-negative bacteremia. A synergism for the development of experimental nephrotoxic acute renal failure. J Clin Invest. 1986;78(1):196–204.
  • Zager RA, O’Quigley J, Zager BK, et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis. 1989;13(3):210–216.
  • Andronesi AG, Tanase AD, Sorohan BM, et al. Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma. Cancer Med. 2019;8(6):3278–3285.
  • Klaus R, Niyazi M, Lange-Sperandio B. Radiation-induced kidney toxicity: molecular and cellular pathogenesis. Radiat Oncol. 2021;16(1):43.
  • Tsagalis G, Akrivos T, Alevizaki M, et al. Long-term prognosis of acute kidney injury after first acute stroke. Clin J Am Soc Nephrol. 2009;4(3):616–622.
  • Lopes JA, Fernandes P, Jorge S, et al. Acute kidney injury in intensive care unit patients: a comparison between the RIFLE and the acute kidney injury network classifications. Crit Care. 2008;12(4):R110.
  • Haase M, Bellomo R, Matalanis G, et al. A comparison of the RIFLE and acute kidney injury network classifications for cardiac surgery–associated acute kidney injury: a prospective cohort study. J Thorac Cardiovasc Surg. 2009;138(6):1370–1376.
  • Kersting S, Dorp SV, Theobald M, et al. Acute renal failure after nonmyeloablative stem cell transplantation in adults. Biol Blood Marrow Transplant. 2008;14(1):125–131.
  • Parikh CR, Schrier RW, Storer B, et al. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis. 2005;45(3):502–509.
  • Lopes JA, Gonçalves S, Jorge S, et al. Contemporary analysis of the influence of acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival. Bone Marrow Transplant. 2008;42(9):619–626.
  • Gutiérrez-García G, Villarreal J, Garrote M, et al. Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis. Bone Marrow Transplant. 2020;55(7):1264–1271.
  • Sakaguchi M, Nakayama K, Yamaguchi H, et al. Risk factors for acute kidney injury and chronic kidney disease following allogeneic hematopoietic stem cell transplantation for hematopoietic malignancies. Acta Haematol. 2020;143(5):452–464.